No immediate trading implications. The filing represents standard corporate governance procedures with no material changes to company strategy or financial outlook.
Price Chart
Executive Summary
Viridian Therapeutics filed a definitive proxy statement (DEFA14A) for its 2026 Annual Meeting, where shareholders will vote on electing two Class II directors, ratifying KPMG LLP as auditors, and approving executive compensation on an advisory basis. The filing is routine and reflects standard corporate governance procedures.
Key Financial Metrics
Key Facts
- Filing is a definitive proxy statement (DEFA14A) for the 2026 Annual Meeting
- Shareholders will vote on electing two Class II directors: Tomas Kiselak and Jennifer K. Moses
- Proposal to ratify KPMG LLP as independent registered public accounting firm
- Advisory vote on executive compensation and frequency of say-on-pay votes
Financial Impact
No direct financial impact - routine governance filing
Risk Factors
- None identified - this is a routine filing with no unexpected developments
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-160349 |
| Document: 0001193125-26-160349-index-headers.html | 0001193125-26-160349 |
| Document: 0001193125-26-160349-index.html | 0001193125-26-160349 |
| Document: 0001193125-26-160349.txt | 0001193125-26-160349 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 6, 2026 11w ago | 8-K | $22.51 $22.96 | ▲ +2.00% | ▲ +1.40% | $23.87 (+6.04%) |
May 28, 2026 21w ago | 8-K | $17.62 $18.79 | ▲ +6.64% | ▲ +8.43% | $23.87 (+35.47%) |
May 26, 2026 21w ago | 8-K | $17.26 $17.39 | ▲ +0.75% | ▲ +2.65% | $23.87 (+38.30%) |
May 8, 2026 24w ago | 424B5 | $17.20 $16.31 | ▲ +5.17% | ▲ +4.87% | $23.87 (−38.78%) |
May 5, 2026 24w ago | 424B5 | $17.53 $16.35 | ▼ −6.73% | ▼ −9.51% | $23.87 (+36.17%) |
May 5, 2026 25w ago | 8-K | $18.75 $15.87 | ▼ −15.36% | ▼ −20.31% | $23.87 (+27.31%) |
Apr 17, 2026 27w ago | DEFA14A | $14.80 $17.43 | ▲ +17.77% | ▲ +12.40% | $23.87 (+61.28%) |
Feb 26, 2026 34w ago | 8-K | $29.49 $28.20 | ▼ −4.37% | ▲ +2.03% | $23.87 (−19.06%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers